Theravance, Inc. (THRX) Reports Q4 Loss of $0.45, Sales Fall Short
Tweet
Share
E-mailGet Alerts THRX Hot Sheet
Price: $4.06 --0%
Financial Fact:
General and administrative: 5.11M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
General and administrative: 5.11M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Theravance, Inc. (NASDAQ: THRX) reported Q4 EPS of ($0.45), $0.06 worse than the analyst estimate of ($0.39). Revenue for the quarter came in at $5.4 million versus the consensus estimate of $6.87 million.
For earnings history and earnings-related data on Theravance, Inc. (THRX) click here.
For earnings history and earnings-related data on Theravance, Inc. (THRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- DA Davidson Reiterates Buy Rating on Walmart (WMT) Ahead of Earnings
- Is Treasury selloff a major issue for stock market bulls?
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
